Alector, Inc. (ALEC) vs Enanta Pharmaceuticals, Inc. (ENTA)
- Alector, Inc. ALEC 2.30 +10.05%
- Enanta Pharmaceuticals, Inc. ENTA 11.00 +9.13%
Alector, Inc. and Enanta Pharmaceuticals, Inc. are both Biotechnology companies. Alector, Inc. and Enanta Pharmaceuticals, Inc. are of similar size ($309.9M and $293.6M). Enanta Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Alector, Inc. trades at 6.6×. Alector, Inc. grew revenue faster over the last twelve months: 151.2% against 0.70%. Alector, Inc. has the higher net margin (23.9% vs −96.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Alector, Inc. leads on 12 and Enanta Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | ALEC | ENTA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | 20.16% | (89.99%) | 0.00% |
| Net margin | 23.87% | (96.89%) | 0.00% |
| Free cash flow margin | (86.40%) | (56.60%) | 0.00% |
| Return on equity | 47.52% | (70.12%) | (51.96%) |
| Return on assets | 16.53% | (21.15%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack